Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-29

Clinical Trial Update: Stem Cells in Spinal Cord Injury [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for a stem cell therapy in spinal cord injury across Phase 2 and Phase 3 stages; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stem cell therapy (Neuroplast sponsor)

Snippet

Sponsor: Neuroplast | Conditions: Spinal Cord Injuries, Acute Spinal Cord Injury | Phase 2, Phase 3 | Status: UNKNOWN